TABBAA, I.;CAZAUX, M.;LALANDE, R., BULL. SOC. CHIM. BELG., 1983, 92, N 11-12, 1011-1018
作者:TABBAA, I.、CAZAUX, M.、LALANDE, R.
DOI:——
日期:——
HEPATITIS C VIRUS INHIBITORS
申请人:Bristol-Myers Squibb Company
公开号:EP1863793B1
公开(公告)日:2012-07-04
INDOLIN-2-ONES AND AZA-INDOLIN-2-ONES
申请人:Diels Gaston Stanislas Marcella
公开号:US20100190786A1
公开(公告)日:2010-07-29
The present invention relates to compounds or pharmaceutically-acceptable salts thereof, processes for preparing them, pharmaceutical compositions containing them and their use in therapy. The invention particularly relates to certain indolin-2-ones and aza-indolin-2-ones which possess anti-tumour activity and are accordingly useful in methods of treatment of the human or animal body, in particular such compounds are useful in the treatment of pathological processes which involve an aberrant cellular proliferation, such as tumor growth, rheumatoid arthritis, restenosis and atherosclerosis.
US7192982B2
申请人:——
公开号:US7192982B2
公开(公告)日:2007-03-20
Tabbaa, I.; Cazaux, M.; Lalande, R., Bulletin des Societes Chimiques Belges, 1983, vol. 92, # 11-12, p. 1011 - 1018